期刊文献+

联合阻断CD28/B7和ICOS对同种异体C57BL/6小鼠皮肤移植的影响

The effect of costimulatory blockade with anti-inducible costimulator antibody combined with CTLA4Ig on prevention of skin allograft rejection
原文传递
导出
摘要 目的探讨CD28/B7共刺激通路阻断剂和ICOS/ICOSL共刺激通路阻断剂对同种异体小鼠皮肤移植的影响。方法实验动物随机分为4组,每组6只,供体、受体均为C57BL/6。CTLA4Ig处理组;ICOSIg处理组;CTLA4Ig+ICOSIg处理组;空白对照组。将C57BL/6小鼠背部全层皮肤移植于同种小鼠中段背部。前3组分别以150mg/kg的抗体经腹腔注射,空白对照组只注射同等量的生理盐水,注射时间为皮肤移植后0、2、4d,术后观察皮肤存活情况。术后6d分别处死各组受体鼠和供体鼠,取受体脾脏淋巴细胞与供体脾脏淋巴细胞作混合淋巴细胞反应(MLR),用MTT法测定细胞活力和细胞增殖反应。术后7d切取皮肤移植物作组织学分析。结果与对照组相比,各阻断剂单独治疗组能明显延长移植物的存活时间(<0.05),各阻断剂治疗组淋巴细胞对供体淋巴细胞产生特异性低反应(<0.05),能有效抑制淋巴细胞对同种抗原的免疫应答。组织学检查发现,各抗体治疗组移植皮肤结构基本正常。结论 CTLA4Ig、ICOSIg可以抑制免疫应答,诱导移植皮肤发生免疫耐受,延长存活时间。 Objective To study the effects of costimulatory blockade with ICOS-Ig combined with CTLA4Ig on prevention of skin allograft rejection.Methods Allogenetic full-thickness skin graft was performed in the middle of the back and transplanted into 24 C57BL/6 mice whose were divided averagely into four groups in random:CTLA4-Ig treatment group,ICOS Ig treatment group,CTLA4Ig+ICOSIg treatment group and Control group.The corresponding antibodies were injected intraabdominally with a dose of 150mg/kg at day 0,2,4 after skin graft in CTLA4-Ig,ICOS Ig and CTLA4Ig+ICOSIg groups,but just injected the same amount of normal saline.The survival graft was observed after transplantation.Recipient mice and donor mice were killed at day 6.Mixed lymphocyte responses(MLR)of the spleen cells were performed respectively,the activity and proliferation ability of the cells were determined by MTT method,histology of the skin graft was observed HE staining.Results The survival time was obviously prolonged(P〈0.05)with low immunoreaction to donor lymphocyte(P〈0.05)in CTLA4-Ig and ICOSIg and CTLA4Ig+ICOSIg groups than in normal controls.Histological examination found that the transplanted skins were essentially normal in antibody treatment groups.Conclusions CTLA4Ig and ICOSIg can restrain the immune response of skin transplantation,induce immunotolerance and prolong the survival time of the graft.
出处 《解剖科学进展》 CAS 2011年第6期571-574,共4页 Progress of Anatomical Sciences
基金 山东省科技攻关计划(No.2008GG102045) 山东省优秀中青年科学家科研奖励基金(No.2007Bs03031) 山东省教育厅资助项目(No.J08LH68)
关键词 皮肤移植 混合淋巴细胞反应 CTLA4 ICOS C57BL/6小鼠 skin transplantation mixed lymphocyte responses CTLA4 ICOS C57BL/6 mice
  • 相关文献

参考文献9

  • 1Hutloff A, Ditlrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28[J]. Nature,1999, 397(6716): 263-266.
  • 2Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS[J]. Nature, 1999, 402: 827-832.
  • 3Mages HW, Hutloff A, Heuck G, et al. Molecular cloning and char acterization Of murine ICOS and identification of B7h as ICOS lisand[J]. Eur J Imnmnol, 2000, 30: 1040-1047.
  • 4Tafur A, Shahinian A, Bladt F, et al. ICOS is essential for effective T-helper-cell reponses[J]. Nature, 2001, 409: 105-108.
  • 5钟鑫平,赵国华,刘永锋.联合阻断CD28/B7和ICOS对大鼠肝移植免疫耐受的实验研究[J].陕西医学杂志,2006,35(10):1248-1250. 被引量:3
  • 6张娇,王又东,张劲松.联合阻断CD28和ICOS对兔高危角膜移植排斥反应的影响[J].国际眼科杂志,2007,7(3):665-667. 被引量:2
  • 7Kosuge H, Suzuki J, Gotoh R, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway[J]. Transplantation, 2003, 75(8): 1374-1379.
  • 8Guo L, Fujino M, Kimura H, et al. AdCTLA-d.Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model[J]. Transpl Int, 2004, 17: 15-21.
  • 9Tai CY, Weber RV, Mackinnon SE, et al. Multiple costimulatory blockade in the peripheral nerve allograft[J]. Neurol Res, 2010, 32(3): 332-336.

二级参考文献20

  • 1钟敬祥,朱春玲,徐锦堂,李辰,刘莲.角膜移植患者外周血中T细胞CD28分子的表达及其意义[J].眼科新进展,2005,25(2):130-131. 被引量:5
  • 2史伟云,谢立信.重视角膜移植术后免疫排斥反应的防治[J].中华眼科杂志,2006,42(1):3-5. 被引量:28
  • 3李琦,席兴华.角膜移植免疫排斥反应防治的研究进展[J].国际眼科杂志,2006,6(5):1126-1129. 被引量:12
  • 4Dong C,Jueds AE,Temann UA,et al.ICOS costimulatory receptor is essential for T-cell activation and function.Nature,2001; 409:102
  • 5Tafuri A,Shahinian A,Bladt F,et al.ICOS is essential for effective T-helper cell responses.Nature,2001;409:105
  • 6Ohba M,Tosuka T,Kanai T,et al.Long-term graft acceptance in rat heart transplantation by CTLA41g gene ransplantation combined with FTY72treatment.World Surg,2001;25(4):391
  • 7Tomasoni S,Sporici RA,Beswick RL,et al.CTLA4Ig gene transfer prologs survival and induces donor-spetific tolerrace in a rat renal allograft.Am Soc Nephrol,2000;11(4):747
  • 8Tamatani T,MeAdam AJ,Greenwald R J,et al.AILIM./ICOS:a novel lymphocyte adhesion molecule.Int Immunol,2000;12(1):51
  • 9Ozkaynak E,Adson MA,Vanheerden JA,et al.Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection Nat Immunol,2001;2(7):591
  • 10Sakamoto S,June CH,Led JA,et al.AILIM/ICOS:its exeression and functional analysis with momoclonal antibodies.Hybrid Hybridomics,2001; 2(7):402

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部